Dr. Leverenz is the Director of the Cleveland Clinic Lou Ruvo Center for Brain Health, Cleveland, and the Joseph Hahn MD Endowed Chair of the Neurological Institute at Cleveland Clinic. His primary clinical and research interests are the aging associated neurological disorders, with a particular focus on Alzheimer's disease, Parkinson's disease, and dementia with Lewy bodies. He is an investigator in the Michael J Fox Foundation sponsored Parkinson's Progression Marker Initiative (PPMI) study and is the pathology core leader for PPMI program. He also chairs the scientific advisory council for the Lewy Body Dementia Association (LBDA) and is on the professional advisory board for the Cleveland Chapter of the Alzheimer's Association.
Dr. Leverenz received his undergraduate and medical education at the University of Washington in Seattle and his neurology training at the New York Hospital Cornell Medical Center. He completed a neuropathology fellowship at the University of Chicago. Prior to arriving in Cleveland in 2014, he was a Professor of Neurology at the University of Washington in Seattle, where he was the director of the clinical research program for the University of Washington Parkinson's disease research center of excellence ("Udall Center") and was an investigator in the Alzheimer's Disease Research Center and the VA based Geriatric and Parkinson's Disease Research Education and Clinical Centers (GRECC and PADRECC).